Literature DB >> 30337363

Antitumor synergy with SY-1425, a selective RARα agonist, and hypomethylating agents in retinoic acid receptor pathway activated models of acute myeloid leukemia.

Michael R McKeown1, Liv Johannessen2, Emily Lee1, Christopher Fiore1, Emmanuelle di Tomaso1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30337363      PMCID： PMC6442965          DOI： 10.3324/haematol.2018.192807

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases.

Authors:  Bodo Brueckner; Regine Garcia Boy; Pawel Siedlecki; Tanja Musch; H Christian Kliem; Piotr Zielenkiewicz; Sandor Suhai; Manfred Wiessler; Frank Lyko
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

2.  Genomic Classification and Prognosis in Acute Myeloid Leukemia.

Authors:  Elli Papaemmanuil; Moritz Gerstung; Hartmut Döhner; Peter J Campbell; Lars Bullinger; Verena I Gaidzik; Peter Paschka; Nicola D Roberts; Nicola E Potter; Michael Heuser; Felicitas Thol; Niccolo Bolli; Gunes Gundem; Peter Van Loo; Inigo Martincorena; Peter Ganly; Laura Mudie; Stuart McLaren; Sarah O'Meara; Keiran Raine; David R Jones; Jon W Teague; Adam P Butler; Mel F Greaves; Arnold Ganser; Konstanze Döhner; Richard F Schlenk
Journal:  N Engl J Med       Date:  2016-06-09       Impact factor: 91.245

3.  Long-term medical costs and life expectancy of acute myeloid leukemia: a probabilistic decision model.

Authors:  Han-I Wang; Eline Aas; Debra Howell; Eve Roman; Russell Patmore; Andrew Jack; Alexandra Smith
Journal:  Value Health       Date:  2014-03       Impact factor: 5.725

4.  Myelodysplastic syndromes, version 2.2015.

Authors:  Peter L Greenberg; Richard M Stone; Rafael Bejar; John M Bennett; Clara D Bloomfield; Uma Borate; Carlos M De Castro; H Joachim Deeg; Amy E DeZern; Amir T Fathi; Olga Frankfurt; Karin Gaensler; Guillermo Garcia-Manero; Elizabeth A Griffiths; David Head; Virginia Klimek; Rami Komrokji; Lisa A Kujawski; Lori J Maness; Margaret R O'Donnell; Daniel A Pollyea; Bart Scott; Paul J Shami; Brady L Stein; Peter Westervelt; Benton Wheeler; Dorothy A Shead; Courtney Smith
Journal:  J Natl Compr Canc Netw       Date:  2015-03       Impact factor: 11.908

Review 5.  Treating acute myeloid leukemia in older adults.

Authors:  Eunice S Wang
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2014-11-18

6.  Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist.

Authors:  Michael R McKeown; M Ryan Corces; Matthew L Eaton; Chris Fiore; Emily Lee; Jeremy T Lopez; Mei Wei Chen; Darren Smith; Steven M Chan; Julie L Koenig; Kathryn Austgen; Matthew G Guenther; David A Orlando; Jakob Lovén; Christian C Fritz; Ravindra Majeti
Journal:  Cancer Discov       Date:  2017-07-20       Impact factor: 39.397

Review 7.  Tamibarotene.

Authors:  Ishido Miwako; Hiroyuki Kagechika
Journal:  Drugs Today (Barc)       Date:  2007-08       Impact factor: 2.245

Review 8.  Targeting epigenetic pathways in acute myeloid leukemia and myelodysplastic syndrome: a systematic review of hypomethylating agents trials.

Authors:  Seongseok Yun; Nicole D Vincelette; Ivo Abraham; Keith D Robertson; Martin E Fernandez-Zapico; Mrinal M Patnaik
Journal:  Clin Epigenetics       Date:  2016-06-14       Impact factor: 6.551

9.  Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer.

Authors:  Maryse Lemaire; Guy G Chabot; Noël Jm Raynal; Louise F Momparler; Annie Hurtubise; Mark L Bernstein; Richard L Momparler
Journal:  BMC Cancer       Date:  2008-05-02       Impact factor: 4.430

10.  Specific uptake of retinoids into human promyelocytic leukemia cells HL-60 by retinoid-specific binding protein: possibly the true retinoid receptor.

Authors:  Y Hashimoto; H Kagechika; E Kawachi; K Shudo
Journal:  Jpn J Cancer Res       Date:  1988-04
View more
  2 in total

Review 1.  All-trans retinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells.

Authors:  Chi H Nguyen; Alexander M Grandits; Louise E Purton; Heinz Sill; Rotraud Wieser
Journal:  Cell Cycle       Date:  2020-09-08       Impact factor: 4.534

Review 2.  Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia-Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation.

Authors:  Øystein Bruserud; Galina Tsykunova; Maria Hernandez-Valladares; Hakon Reikvam; Tor Henrik Anderson Tvedt
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.